Related Experiment Videos
Obese men with type IIB hyperlipidemia are insulin resistant
P Karhapää1, E Voutilainen, M Malkki
1Department of Medicine, Kuopio University Hospital, Finland.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|October 1, 1993
Summary
Patients with type IIB hyperlipidemia exhibit significant insulin resistance, characterized by lower glucose uptake and oxidation rates. This study highlights impaired glucose metabolism in this patient group.
Area of Science:
- Metabolic disorders
- Endocrinology
- Cardiovascular research
Background:
- Type IIB hyperlipidemia (HLIIB) is characterized by elevated cholesterol and triglycerides.
- Insulin resistance is a common comorbidity in metabolic disorders.
- Understanding insulin sensitivity in HLIIB is crucial for managing associated cardiovascular risks.
Purpose of the Study:
- To quantify insulin resistance in obese patients with type IIB hyperlipidemia.
- To compare glucose and lipid metabolism between HLIIB patients and matched controls.
Main Methods:
- Euglycemic clamp technique to assess insulin sensitivity.
- Indirect calorimetry to measure glucose and lipid oxidation rates.
- Careful matching of patients and controls for age, sex, and obesity.
Main Results:
- HLIIB patients showed significantly higher fasting plasma insulin levels compared to controls.
- Whole-body glucose uptake and glucose oxidation rates were significantly lower in HLIIB patients.
- Lipid oxidation was less suppressed in HLIIB patients during the clamp, indicating altered lipid metabolism.
Conclusions:
- Obese patients with type IIB hyperlipidemia demonstrate significant insulin resistance.
- Impaired glucose metabolism, including reduced uptake and oxidation, is a key feature.
- These findings suggest a link between hyperlipidemia and metabolic dysfunction, potentially increasing cardiovascular risk.